Clinical trial
Alpha Lipoic Acid in the Treatment of Diabetic Retinopathy
NCT01208948 is registered in ClinicalTrials.gov with Ludwig-Maximilians - University of Munich as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Alpha Lipoic Acid in the Treatment of Diabetic Retinopathy
- Lead sponsor
- Ludwig-Maximilians - University of Munich
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2000
- Completion date
- December 31, 2005
- Enrollment
- 520 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.